HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Timing of response and long term efficacy of Omalizumab in non-clonal Mast Cell Activation Syndrome: A case series.

AuthorsMarco Caminati, Elisa Olivieri, Francesca Nalin, Roberta Zanotti, Gianenrico Senna, Michele Schiappoli, Annarita Dama, Patrizia Bonadonna
JournalEuropean journal of internal medicine (Eur J Intern Med) Vol. 71 Pg. 104-106 (01 2020) ISSN: 1879-0828 [Electronic] Netherlands
PMID31735545 (Publication Type: Case Reports, Letter)
Chemical References
  • Omalizumab
Topics
  • Humans
  • Mast Cells
  • Mastocytosis
  • Omalizumab (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: